Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Advanced Robotic Navigated Bronchoscopy System Ushers in New Era in Lung Nodule Biopsy

By HospiMedica International staff writers
Posted on 10 Mar 2023

Most potentially cancerous growths are situated in the outer third of the lungs, which poses a challenge for doctors to perform accurate biopsies. More...

Current technologies suffer from limitations in accessing and precisely targeting these suspicious lesions. Now, a robotic navigated bronchoscopy system integrates real-time tomosynthesis and utilizes a disposable bronchoscope, ushering in a new era in lung nodule biopsy.

The Galaxy System by Noah Medical (San Carlos, CA, USA) is a robotic navigated bronchoscopy system featuring advanced imaging technologies that provide real-time location updates, and are designed to improve tool-in-lesion and diagnostic yield. The Galaxy System features TiLT+ Technology with integrated tomosynthesis and augmented fluoroscopy. The system’s always-on-camera bronchoscope enables direct visualization for the entire procedure, including at the time of biopsy. It features a purpose-built 4-way bronchoscope articulation that makes navigation to even the most peripheral lesions possible.

The Galaxy System is the only robotic navigated bronchoscopy system on the market to feature a single-use, disposable bronchoscope, specifically to improve efficiency and workflow, as well as minimize the risk of cross-contamination. The system has won positive reviews from pulmonologists and thoracic surgeons who have used the system as part of pre-clinical studies and multiple technology demonstrations around the U.S. in 2022. Noah has now received FDA clearance of the Galaxy System and its accessories which are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures.

“While various technologies to diagnose lung cancer have been utilized over time, the diagnostic yield has remained relatively low,” said Jian Zhang, PhD, Noah Medical founder and CEO. “The Galaxy System is designed to close this gap in the market, giving clinicians a safe and easy-to-use platform to potentially improve diagnostic yield and produce better clinical outcomes. With this FDA clearance, we are excited to move into the commercial phase of our journey.”

Related Links:
Noah Medical 


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Premium Air-Mattress
MA-51
Radiology System
Riviera SPV AT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.